NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹8.12 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹50 Cr |
Mar2021 | ₹57 Cr |
Mar2020 | ₹8.12 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | 101.67 | |
Mar2023 | ₹20 Cr | -59.05 | |
Mar2022 | ₹50 Cr | -11.91 | |
Mar2021 | ₹57 Cr | 597.03 | |
Mar2020 | ₹8.12 Cr | - |
Compare Consolidated Net Profit of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹787.4 Cr | 3.1% | 19.8% | -49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹185,609.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 3.1% |
19.8% |
-49.3% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses